Cor Vasa 2025, 67(5):614-619 | DOI: 10.33678/cor.2025.027

Association of insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene (ACE) with ST segment elevation myocardial infarction and factors risk in Western Algeria: case-control study

Asma Amrani-Midouna, b, Nadia Laredjc, Taki Djebailib, d, Djelti Mouniab, d, Abdelkader Djelloulb, d, Lilia Zoulib, d, Hamid Aoumeurb, d, Nachi Mouradb, d
a Biotechnology Department, Faculty of Sciences of Nature and Life, University of Oran 1 Ahmed Benbella, Algeria
b Medical Biochemistry and Molecular Biology Laboratory, Faculty of Medicine, University of Oran 1 Ahmed Benbella, Algeria
c Cardiology Department, Faculty of Medicine, University-Hospital-Center of Oran, University of Oran 1 Ahmed Benbella, Algeria
d Biochemistry Service, Faculty of Medicine, University of Oran 1 Ahmed Benbella, Algeria

Background: Cardiovascular diseases are the leading cause of mortality worldwide. Acute coronary syndrome (ACS) is a multifactorial disease resulting from the interaction of environmental and genetic factors. The I/D polymorphism of the ACE gene has been associated with the risk of developing acute coronary syndrome (ACS). Our case-control study aimed to access the potential association of insertion/deletion (I/D) ACE (angiotensin converting enzyme) gene polymorphism and ST segment elevation myocardial infarction (STEMI) among a sample of Algerian patients from Western Algeria.

Methods: We conducted a case-control study comprising 169 individuals including 70 healthy subjects and 99 STEMI patients. ACE I/D polymorphism was detected by polymerase chain reaction with specific primers.

Results: The prevalence of DD, ID, and II genotypes in our patients group were 48.48%, 43.43%, and 8.08%respectively vs 2.85%, 35.75% and 61.42% in the control group. These results showed that the frequency of the DD genotype and the D allele was significantly higher in cases with ACS compared to controls (χ2 = 67.63; P = 0.0001) (P < 0.05, OR = 9.03, 95% CI: 5.41-15.01). We also noticed that there was no significant association between ACE I/D polymorphisms and STEMI-relevant traditional risk factors like age, gender, diabetes mellitus, hypertension, smoking.

Conclusion: In conclusion, these results suggest a statistically significant association between the I/D polymorphism of the ACE gene and the risk of developing ACS in the studied sample.

Keywords: Acute coronary syndrome (ACS), Case-control study, I/D ACE gene polymorphism, PCR, Western Algerian population

Received: February 5, 2025; Revised: February 5, 2025; Accepted: February 13, 2025; Prepublished online: June 2, 2012; Published: November 6, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Amrani-Midoun A, Laredj N, Djebaili T, Mounia D, Djelloul A, Zouli L, et al.. Association of insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene (ACE) with ST segment elevation myocardial infarction and factors risk in Western Algeria: case-control study. Cor Vasa. 2025;67(5):614-619. doi: 10.33678/cor.2025.027.
Download citation

References

  1. Dai X, Wiernek S, Evans JP, Runge MS. Genetics of coronary artery disease and myocardial infarction. World J Cardiol 2016;8:1-23. Go to original source...
  2. Amrani-Midoun A LN, Djebaili T, et al. Gender differences in epidemiology and risk factors of acute coronary syndrome in Algerian patients of the Oran city: descriptive cross-sectional study. Cor Vasa 2023;65:496-500. Go to original source...
  3. Das SR, Alexander KP, Chen AY, et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol 2011;58:2642-2650. Go to original source...
  4. Amrani A, Baba Hamed MB. Relationship between angiotensinogen gene T174 M polymorphism and essential hypertension in a sample of Algerian population: case control study. Journal of Medical Sciences 2014;14:168-173. Go to original source...
  5. Amrani A, Baba Hamed MB, Mesli Talebbendiab F. Association study between some renin-angiotensin system gene variants and essential hypertension in a sample of Algerian population: case control study. Ann Biol Clin (Paris) 2015;73:557-563. Go to original source...
  6. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644. Go to original source...
  7. Lin C, Yang HY, Wu CC, et al. Angiotensin-converting enzyme insertion/deletion polymorphism contributes high risk for chronic kidney disease in Asian male with hypertension--a meta-regression analysis of 98 observational studies. PloS one 2014;9:e87604. Go to original source...
  8. Sakhteh M, Poopak B, Amirizadeh N, et al. Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease. J Renin Angiotensin Aldosterone Syst 2015;16:1168-1174. Go to original source...
  9. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52:639-672. Go to original source...
  10. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation 2012;125:1043-1052. Go to original source...
  11. Zintzaras E, Raman G, Kitsios G, Lau J. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 2008;168:1077-1089. Go to original source...
  12. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 2000;20:484-492. Go to original source...
  13. Meroufel DN, Mediene-Benchekor S, Dumont J, et al. A study on the polymorphisms of the renin-angiotensin system pathway genes for their effect on blood pressure levels in males from Algeria. J Renin Angiotensin Aldosterone Syst 2014;15:1-6. Go to original source...
  14. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 2013;82:E1-E27. Go to original source...
  15. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;123:2022-2060. Go to original source...
  16. Jneid H, Addison D, Bhatt DL, et al. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes 2017;10:e000032. Go to original source...
  17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215. Go to original source...
  18. Chou HT, Tsai CH, Tsai FJ. Association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and risk of rheumatic heart disease. Jpn Heart J 2004;45:949-957. Go to original source...
  19. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association. Circulation 2015;131:e29-e322. Go to original source...
  20. Cambien F. The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin Genet 1994;46(1 Spec No):94-101. Go to original source...
  21. Chen Y, Dong S, He M, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and risk of myocardial infarction in an updated meta-analysis based on 34993 participants. Gene 2013;522:196-205. Go to original source...
  22. Samani NJ, Thompson JR, O'Toole L, et al. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996;94:708-712. Go to original source...
  23. Palmer BR, Pilbrow AP, Yandle TG, et al. Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. J Am Coll Cardiol 2003;41:729-736. Go to original source...
  24. Mehri S, Mahjoub S, Farhati A, et al. Angiotensinogen gene polymorphism in acute myocardial infarction patients. J Renin Angiotensin Aldosterone Syst 2011;12:42-47. Go to original source...
  25. Martinez-Quintana E, Chirino R, Nieto-Lago V, et al. Prognostic value of ACE I/D, AT1R A1166C, PAI-I 4G/5G and GPIIIa a1/a2 polymorphisms in myocardial infarction. Cardiol J 2014;21:229-237. Go to original source...
  26. Amara A, Mrad M, Sayeh A, et al. The Effect of ACE I/D Polymorphisms Alone and With Concomitant Risk Factors on Coronary Artery Disease. Clin Appl Thromb Hemost 2018;24:157-163. Go to original source...
  27. Hmimech W, Idrissi HH, Diakite B, et al. Impact of I/D polymorphism of angiotensin-converting enzyme (ACE) gene on myocardial infarction susceptibility among young Moroccan patients. BMC Res Notes 2017;10:763. Go to original source...
  28. Tran DC, Le LHG, Thai TT, et al. Association between ACE I/D genetic polymorphism and the severity of coronary artery disease in Vietnamese patients with acute myocardial infarction. Front Cardiovasc Med 2023:10:1091612. Go to original source...
  29. Baruah S, Chaliha MS, Borah PK, et al. Insertion/Insertion Genotype of Angiotensin I-Converting-Enzyme Gene Predicts Risk of Myocardial Infarction in North East India. Biochem Genet 2016;54:134-146. Go to original source...
  30. Yoshida M, Iwai N, Ohmichi N, et al. D allele of the angiotensin-converting enzyme gene is a risk factor for secondary cardiac events after myocardial infarction. Int J Cardiol 1999;70:119-125. Go to original source...
  31. Zhao W, Ma ST, Cui LQ. Meta-analysis of angiotensin-converting enzyme insertion/deletion polymorphism and myocardial infarction in Han Chinese. Genet Mol Res 2015;14:8068-8076. Go to original source...
  32. Dai S, Ding M, Liang N, et al. Associations of ACE I/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients. Sci Rep 2019;9:19719. Go to original source...
  33. Vaisi-Raygani A, Ghaneialvar H, Rahimi Z, et al. The angiotensin converting enzyme D allele is an independent risk factor for early onset coronary artery disease. Clin Biochem 2010;43:1189-1194. Go to original source...
  34. Parenica J, Goldbergova MP, Kala P, et al. ACE gene insertion/deletion polymorphism has a mild influence on the acute development of left ventricular dysfunction in patients with ST elevation myocardial infarction treated with primary PCI. BMC Cardiovasc Disord 2010:10:60. Go to original source...
  35. Moorthy N, Saligrama Ramegowda K, et al. Role of Angiotensin-Converting Enzyme (ACE) gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction. Int J Cardiol Heart Vasc 2021;32:100701. Go to original source...
  36. Krishnan R, Sekar D, Karunanithy S, Subramanium S. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with essential hypertension in south Indian population. Genes Dis 2016;3:159-163. Go to original source...
  37. Siddharth KM, Kapur S, Ram CV. Angiotensin converting enzyme gene polymorphism and hypertension: no ace yet in the pack of cards. J Assoc Physicians India 2012;60:9-10.
  38. Borah PK, Shankarishan P, Hazarika NC, Mahanta J. Hypertension subtypes and angiotensin converting enzyme (ACE) gene polymorphism in Indian population. J Assoc Physicians India 2012;60:11, 15-17.
  39. Mahwish UN, Ponnaluri KC, Heera B, et al. Link between ACE I/D Gene Polymorphism and Dyslipidemia in Diabetic Nephropathy: A Case-control Study from Hyderabad, India. Indian J Nephrol 2020;30:77-84. Go to original source...
  40. Ha SK. ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information. J Diabetes Res 2014;2014:846068. Go to original source...
  41. Schmidt S, Schone N, Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 1995;47:1176-1181. Go to original source...
  42. Wang Y, Peng W, Zhang X, et al. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan. J Renin Angiotensin Aldosterone Syst 2016;17:1470320316666749. Go to original source...
  43. Amrani-Midoun A LN, Boukerche F. DNA methylation and coronary artery disease: Brief summary of the main findings. Cor Vasa 2023;65:843-847. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.